Ultra-Fast Acting Insulin Analogues

ISSN: 2212-3334 (Online)
ISSN: 1872-2148 (Print)

Volume 11, 2 Issues, 2017

Download PDF Flyer

Recent Patents on Endocrine Metabolic & Immune Drug Discovery

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Ultra-Fast Acting Insulin Analogues

Recent Patents on Endocrine Metabolic & Immune Drug Discovery, 8(2): 117-123.

Author(s): Sanjay Kalra and Yashdeep Gupta.

Affiliation: Bharti Hospital & B.R.I.D.E., Karnal 132001, India.


Insulin analogues are a major improvement in diabetes pharmacotherapy. Rapid acting insulins have certain advantages over regular insulin, but there is a need to develop even faster acting insulin preparations, which mimic physiological insulin release in a better manner. This review discusses recent developments and patents in the field of Ultra- fast acting insulins. It classifies various approaches towards creation of an Ultra-fast acting insulin profile based upon the method used to achieve a faster onset of action. These include change in formulation of insulin, addition of excipients to insulin, and utilization of novel insulin sites or delivery methods. It examines the current state of evidence, and the developments in the field of newer insulin analogues & delivery methods.


Aspart, diabetes mellitus, fast-acting insulin aspart, insulin, insulin analogues, insulin technique, ultra-fast insulin.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 8
Issue Number: 2
First Page: 117
Last Page: 123
Page Count: 7
DOI: 10.2174/1872214808666140714112644
Price: $100

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science